Page last updated: 2024-08-23

ng-nitroarginine methyl ester and ro 46-8443

ng-nitroarginine methyl ester has been researched along with ro 46-8443 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Breu, V; Clozel, M1
Lavallée, M; Ming, Z; Parent, R; Thorin, E1
Lavallée, M; Parent, R1

Other Studies

3 other study(ies) available for ng-nitroarginine methyl ester and ro 46-8443

ArticleYear
The role of ETB receptors in normotensive and hypertensive rats as revealed by the non-peptide selective ETB receptor antagonist Ro 46-8443.
    FEBS letters, 1996, Mar-25, Volume: 383, Issue:1-2

    Topics: Animals; Arginine; Blood Pressure; Endothelin Receptor Antagonists; Hypertension; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Peptides, Cyclic; Pyrimidines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Endothelin B; Receptors, Endothelin; Sulfonamides; Viper Venoms

1996
Contribution of endogenous endothelin to large epicardial coronary artery tone in dogs and humans.
    The American journal of physiology, 1999, Volume: 277, Issue:2

    Topics: Animals; Arteries; Coronary Vessels; Dinoprost; Dioxanes; Dogs; Endothelin Receptor Antagonists; Endothelins; Enzyme Inhibitors; Humans; In Vitro Techniques; NG-Nitroarginine Methyl Ester; Nitroarginine; Pericardium; Pyridines; Pyrimidines; Receptor, Endothelin A; Receptor, Endothelin B; Sulfonamides; Tetrazoles; Vasoconstriction; Vasomotor System

1999
Endothelin-dependent effects limit flow-induced dilation of conductance coronary vessels after blockade of nitric oxide formation in conscious dogs.
    Cardiovascular research, 2000, Jan-14, Volume: 45, Issue:2

    Topics: Adenosine; Analysis of Variance; Animals; Coronary Circulation; Coronary Vessels; Dioxanes; Dogs; Endothelin Receptor Antagonists; Enzyme Inhibitors; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Pyridines; Pyrimidines; Sulfonamides; Tetrazoles; Vasodilator Agents

2000